Denali Therapeutics Inc (DNLI)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$12.51
Buy
$14.49
$-0.30 (-2.22%)
Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Prices updated at 31 May 2025, 00:03 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
$13.45 - $12.92 | |
$33.33 - $10.57 | |
- | |
1,923.46m | |
- | |
- | |
1,205,599 | |
1.71 | |
1,109,011.29 | |
0.89 | |
144.22m | |
US24823R1059 | |
-2.67 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.